Patent Assignment
Reel/Frame 017555/0288
Merger
Recorded: 2006-05-01
Pages: 6
Assignor
EOS BIOTECHNOLOGY, INC.
Executed: 2006-01-09
Assignee
PROTEIN DESIGN LABS, INC.
34801 CAMPUS DRIVE, FREMONT, CALIFORNIA, 94555
Covered Properties
(2)
Novel Methods of Diagnosing of Colorectal Cancer, Compositions, and Methods of Screening for Colorectal Cancer Modulators
Patent:
6,773,878 →
Application:
09/435,945 →
Novel Methods of Diagnosing Cancer, Compositions, and Methods of Screening for Cancer Modulators
Patent:
6,566,502 →
Application:
09/608,821 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
May 1, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017555/0284 →
Assignment of Assignor's Interest
Dec 15, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 023649/0752 →
Change of Name
Dec 7, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025445/0807 →
Change of Name
Nov 5, 2014
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS, INC.
Reel/Frame 034106/0766 →